Insider activity at West Pharmaceutical Services Inc has been all selling for a year now: about $6.6 million from two sellers, and zero buyers at market prices.
That's worth context: executives sell for plenty of routine reasons, from scheduled trading plans to tax bills. Buying is the rarer, more telling signal.
Members of Congress reported 6 trades in WST over the past two years (three members). 2 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Favorite Annette F | Executive Officer | Sell | 2,500 | $355.00 | $888K | SEC |
| Sep 15, 2026 | Favorite Annette F | Executive Officer | Sell | 2,524 | $365.00 | $921K | SEC |
| Sep 15, 2026 | Favorite Annette F | Executive Officer | Sell | 2,500 | $345.00 | $862K | SEC |
| Sep 10, 2026 | Favorite Annette F | Executive Officer | Sell | 2,818 | $340.81 | $960K | SEC |
| Sep 10, 2026 | Favorite Annette F | Executive Officer | Sell | 2,500 | $340.81 | $852K | SEC |
| Sep 10, 2026 | Favorite Annette F | Executive Officer | Sell | 2,817 | $340.81 | $960K | SEC |
| Apr 29, 2026 | Favorite Annette F | Executive Officer | Sell | 2,817 | $305.20 | $860K | SEC |
| Apr 29, 2026 | Winters Chad | Executive Officer | Sell | 896 | $300.67 | $269K | SEC |
| Oct 31, 2024 | Witherspoon Charles | Officer | Sell | 225 | $310.40 | $70K | SEC |
| Oct 31, 2024 | Witherspoon Charles | Officer | Sell | 478 | $310.40 | $148K | SEC |
| Aug 21, 2024 | Witherspoon Charles | Officer | Sell | 500 | $300.00 | $150K | SEC |
| Aug 21, 2024 | Witherspoon Charles | Officer | Sell | 529 | $300.00 | $159K | SEC |
| Aug 21, 2024 | Hofmann Thomas W | Director | Sell | 617 | $365.92 | $226K | SEC |
| Aug 8, 2024 | Green Eric Mark | CEO | Sell | 30,732 | $304.71 | $9.4M | SEC |
| Aug 8, 2024 | Green Eric Mark | CEO | Sell | 41,000 | $366.65 | $15.0M | SEC |
| Filed | Member | Type | Amount | Source |
|---|---|---|---|---|
| Aug 13, 2025 | Lisa C. McClain R | Sale | $1,001 - $15,000 | Official filing |
| Aug 13, 2025 | Lisa C. McClain R | Purchase | $1,001 - $15,000 | Official filing |
| May 8, 2025 | Robert P. Bresnahan, Jr. R | Sale | $1,001 - $15,000 | Official filing |
| Mar 27, 2025 | Robert P. Bresnahan, Jr. R | Purchase | $1,001 - $15,000 | Official filing |
| Mar 6, 2025 | Jared Moskowitz D | Sale | $1,001 - $15,000 | Official filing |
| Dec 9, 2024 | Jared Moskowitz D | Sale | $1,001 - $15,000 | Official filing |
In the last 12 months West Pharmaceutical Services Inc insiders made open-market purchases worth about $0 and sales worth about $6.6 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in WST was filed on 2026-09-15.
Yes. Members of Congress reported 6 trades in WST over the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).